3M™ Kerramax Care™ Border Superabsorbent Wound Dressing with Adhesive Border, sterile, 16 x 26 cm, 5 ST

The 3M™ Kerramax Care™ Border Superabsorbent Wound Dressing with Adhesive Border combines high absorbency with secure fixation. The border design encloses the wound in a sterile manner and provides effective protection against external influences.

The Kerramax Care dressing is a primary or secondary dressing with advanced Exu-Safe™ technology to improve exudate management. The superabsorbent dressings are available with and without an adhesive edge.

How does it work?

The soft non-woven material on both sides makes the patient feel comfortable and ensures excellent transpiration. The unique horizontal capillary layer absorbs serous and viscous ^exudate1 and distributes it evenly horizontally and vertically through the dressing. This utilises full absorbency and prevents swelling.^{2, 3} The super-absorbent core traps exudate,^{*4 bacteria*5} and matrix metal proteinases (MMPs)^5*, reducing the risk of maceration and complications - even under compression.^*4 The soft, flexible, heat-sealed edge profile prevents soaking of the patient's skin and remains clean over a long period of time. It also ensures the patient's comfort.

When should the product be used?

Kerramax Care dressings are suitable for acute and chronic wounds that exude moderately to very heavily, including

• Venous ulcers
• Pressure ulcers
• Diabetic foot ulcers

Suitable for use under all types of compression.

Properties

• Absorbs and binds large amounts of ^exudate6*
• Soft, comfortable on the skin and ^foldable1
• Easy to ^apply1 (can be used on both sides)
• Traps ^bacteria7* and ^MMPs8*

1. Hughes M. A large-scale evaluation of managing moderate and highly exuding wounds in the community. Wounds UK. 2017;13(3):78-85. 2. Cotton S. The management of a chronic leg ulcer using Kerramax Care Super-Absorbent Dressing under compression. Poster presented at Wounds UK; November 2015; Harrogate, UK. 3. Rose R. A large clinical evaluation assessing the tolerance & effectiveness of super-absorbent dressing, Kerramax Care. Poster presented at Wounds UK; November 2015; Harrogate, UK. 4. Lovett J. Free swell absorbency, retention and subjective squeeze testing on KerraMax Care US size (13.5x15.5cm). CHC R267. Knutsford, UK. Crawford Healthcare. 2015. 5. Warde D. An investigation into the ability of KerraMax Care to bind bacteria. CHC R752. Knutsford, UK. Crawford Healthcare. 2018. 6 Jackson, S. & Warde, D. Determination of free swell absorption and fluid retention, and absorption capacity under pressure of KERRAMAX CARE™. Crawford Healthcare Ltd CHC R596. Knutsford, UK: 2017. 7. Thomas, H & Westgate, S.J. An in vitro comparison of MRSA and P. aeruginosa sequestration by five super-absorbent wound dressings. Poster presented at EWMA; 11-13 May 2016; Bremen, Germany. | Dr Cochrane, C.A. Evaluation of matrix metalloproteinases by wound care products. University of Liverpool, UK. July 2011.

Dosage form

Wound dressing sterile

Application

Suitable for use on moderately to heavily exuding wounds, including leg ulcers, pressure ulcers and diabetic foot ulcers.